publication date: May. 11, 2018

Funding Opportunity

DOD publishes Kidney Cancer Research Program Funding Opportunities for FY18

The FY18 Defense Appropriation provides $15 million to the Department of Defense Kidney Cancer Research Program to support the United States Medical Research Acquisition Activity.

DOD is inviting applications for:

Concept Award

Investigators at all academic levels.

Supports highly innovative, untested, potentially groundbreaking concepts in kidney cancer.

Emphasis on innovation.

Funding for clinical trials is not allowed.

Preliminary data are not allowed.

Blinded review

Maximum funding of $75,000 for direct costs (plus indirect costs).

Maximum period of performance is 1 year.

Idea Development Award

Established Investigators:  

Independent investigators at or above the level of Assistant Professor (or equivalent) and 10 years or more from a terminal degree; or

Early Career Investigators:

Investigators at the level of Assistant Professor, Instructor, or Assistant Research Professor (or equivalent) and less than 10 years from a terminal degree (excluding time spent in medical residency or family medical leave) at the time of application submission deadline are eligible.

Supports new ideas that represent innovative, high-risk/high-gain approaches to kidney cancer research, and have the potential to make an important contribution to kidney cancer.

Preliminary data are required.

Innovation and Impact are the most important review criteria.

Funding for clinical trials is not allowed.

FY18 KCRP Areas of Emphasis are strongly encouraged.

Maximum funding of $400,000 in direct costs (plus indirect costs).

Period of performance is not to exceed 2 years.

Physicians Research Award

The PI must be a physician with clinical duties and/or responsibilities … Continue reading DOD publishes Kidney Cancer Research Program Funding Opportunities for FY18

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.